跳至主要内容
临床试验/CTRI/2019/01/017262
CTRI/2019/01/017262招募中4 期

Randomized â?? controlled trialof Mitomycin C vs. Triamcinolone in the management of refractory esophageal strictures inchildren

Rishi Bolia0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • All children ( < 13 years ) with refractory or recurrent esophageal strictures , irrespective of the etiology will be included for the trial.
  • - Refractory strictures will be defined as those in which it is not possible to relieve the
  • anatomic restriction successfully up to a diameter of 14 mm (12.8 mm. in < 5 years) over
  • five sessions at 2-3 weekly intervals, due to cicatricial luminal compromise or fibrosis;
  • - Recurrent strictures will be defined as those in which it is not possible to maintain a
  • satisfactory luminal diameter for 4 wk once the target diameter of 14 mm (12.8 mm < 5 years ) has been achieved

排除标准

  • - All patients who have received Mitomycin C or triamcinolone in the past.
  • - Achalasia cardia
  • - Patients with a history of iatrogenic perforation while undergoing dilataion
  • - Patients / guardian refusal to give consent / assent.

研究者

发起方
Rishi Bolia

相似试验